Rasnadinavak Kwath In The Management Of Amvata

Randomised controlled clinical Study to assess the efficacy of Rasnadinavak Kwath in the management of Amvata - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/078397

Enrollment

Registered

2024-12-20

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age 18 to 60 yrs 2 Irrespective of gender & socio-economic status 3 Patients with signs and symptoms of of Amavata like Sandhishool, Sandhishoth, Sandhistabdhata, Sparshasahatva 4 History of Amavata more than 6 weeks and less than 2 years

Exclusion criteria

Exclusion criteria: 1 Age below 18 yrs and above 60 yrs 2 Pregnant and lactating mothers 3 Patients with heart diseases, DM, HTN and other Chronic systemic diseases 4 Sandhigata Vata and Vatarakta

Design outcomes

Primary

Measure	Time frame
To study efficacy of Rasnadinavak Kwath In AmavataTimepoint: 28 days	—

Secondary

Measure	Time frame
1 To study Amavata in detail as per Ayurvedic aspect 2 To study Rasnadinavak Kwath in detail 3 To compare efficacy of trial and control drugTimepoint: 12 months	—

Countries

India

Contacts

Public ContactDr Abhinandan Patil

LRP Ayurvedic medical college and hospital PG Institute and Research center Urun Islampur

drabhinandanpatil@gmail.com9890205000

Outcome results